| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/02/2004 | US20040170613 Compositions and methods for liver growth and liver protection |
| 09/02/2004 | US20040170608 Use of a lentiviral vector in the treatment of pain |
| 09/02/2004 | US20040170607 Reducing viability of tumor cells by administering a virus; differential sensitivity using interferons |
| 09/02/2004 | US20040170606 Vaccines; medical diagnosis; detection antigen of papilloma virus ; genetic engineering fusion proteins; induce immunology response |
| 09/02/2004 | US20040168708 Contacting with aqueous solutioncapable of shifting adsorption or chemisorption balance; separation |
| 09/02/2004 | DE10306083A1 Erkennungsmoleküle gerichtet gegen ein Survivin-Gen und die Verwendung dieser Recognition molecules directed against a survivin gene and the use of these |
| 09/02/2004 | DE10248141A1 Nukleinsäuren und deren Verwendung für die Gentherapie Nucleic acids and their use for gene therapy |
| 09/02/2004 | DE102004006526A1 Neues Lysindecarboxylase-Gen und Verfahren zur Herstellung von L-Lysin New lysine decarboxylase gene, and methods for producing L-lysine |
| 09/02/2004 | CA2843744A1 Delta-endotoxin genes and methods for their use |
| 09/02/2004 | CA2824150A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2824126A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2787820A1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2753408A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2731504A1 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 09/02/2004 | CA2714863A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2516971A1 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/02/2004 | CA2516777A1 Human cyclooxygenase-3 enzyme and uses thereof |
| 09/02/2004 | CA2516550A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2516544A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2516527A1 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | CA2516520A1 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | CA2516440A1 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 09/02/2004 | CA2516371A1 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | CA2516366A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2516349A1 Delta-endotoxin genes and methods for their use |
| 09/02/2004 | CA2516320A1 Induced activation in dendritic cells |
| 09/02/2004 | CA2516310A1 Efficient gene silencing in plants using short dsrna sequences |
| 09/02/2004 | CA2516293A1 Fusion proteins of interferon alpha muteins with improved properties |
| 09/02/2004 | CA2516286A1 Expression in plants of antibodies against enterotoxigenic escherichia coli |
| 09/02/2004 | CA2516284A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2516221A1 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps) |
| 09/02/2004 | CA2516191A1 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | CA2516042A1 Preparation of transgenic plants comprising a nucleic acid molecule encoding an l450 polypeptide-exhibiting faster growth and/or increased yield |
| 09/02/2004 | CA2515978A1 Vaccination or immunization using a prime-boost regimen against bhv-1 |
| 09/02/2004 | CA2515948A1 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 09/02/2004 | CA2515481A1 An expression cassette and vector for transient or stable expression of exogenous molecules |
| 09/02/2004 | CA2511855A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP1452867A1 DNA specific capacity affinity sensor |
| 09/01/2004 | EP1452608A1 Automated performance of polymerase chain reaction |
| 09/01/2004 | EP1452607A1 Method of selecting barley variety, barley beta-amylase gene and process for producing malt alcoholic drink |
| 09/01/2004 | EP1452601A1 Enhanced expression of fusion polypeptides with a biotinylation tag |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452599A1 Improved epitope displaying phage |
| 09/01/2004 | EP1452598A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 09/01/2004 | EP1452596A1 Environmental stress-responsive promoters and genes encoding transcriptional factor |
| 09/01/2004 | EP1452595A1 ES CELLS WITH ENHANCED RNAi EFFECT |
| 09/01/2004 | EP1452594A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
| 09/01/2004 | EP1452592A1 Rice transposon genes |
| 09/01/2004 | EP1452589A1 ADP-ribosyltransferase c3cer |
| 09/01/2004 | EP1452588A1 Reductase gene and use of the same |
| 09/01/2004 | EP1452585A1 Gamma-glutamylcysteine-producing yeast and method of screening the same |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 09/01/2004 | EP1452540A2 Molecular sequence of swine retrovirus and methods of use |
| 09/01/2004 | EP1452232A2 Method of treating surface of substrate used in biological reaction system |
| 09/01/2004 | EP1451856A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 09/01/2004 | EP1451590A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 09/01/2004 | EP1451581A2 Toll-like receptor 3 signaling agonists and antagonists |
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1451552A2 Reagents and methods useful for detecting diseases of the breast |
| 09/01/2004 | EP1451374A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 09/01/2004 | EP1451370A2 Chromosomal saturation mutagenesis |
| 09/01/2004 | EP1451369A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 09/01/2004 | EP1451368A2 Single nucleotide polymorphisms in gh-1 |
| 09/01/2004 | EP1451367A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 09/01/2004 | EP1451365A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 09/01/2004 | EP1451363A2 Antisense modulation of thyroid hormone receptor interactor 6 expression |
| 09/01/2004 | EP1451358A2 Cell and tissue arrays and microarrays and methods of use |
| 09/01/2004 | EP1451356A1 Method and kit for proximity probing with multivalent proximity probes |
| 09/01/2004 | EP1451353A2 Antisense modulation of phospholipase a2 group v expression |
| 09/01/2004 | EP1451352A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna |
| 09/01/2004 | EP1451351A2 Labelled nucleotides |
| 09/01/2004 | EP1451350A1 Methods, systems, and kits for analysis of polynucleotides |
| 09/01/2004 | EP1451349A2 Biallelic markers of d-amino acid oxidase and uses thereof |
| 09/01/2004 | EP1451348A2 Methods, reagents, kits and apparatus for protein function analysis |
| 09/01/2004 | EP1451346A2 Method of labelling crnas for probing oligo-based microarrays |
| 09/01/2004 | EP1451345A1 Age-associated markers |
| 09/01/2004 | EP1451344A2 Compositions and methods for use in isolation of nucleic acid molecules |
| 09/01/2004 | EP1451338A1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451332A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
| 09/01/2004 | EP1451331A1 A promoter for transformation of monocot plants |
| 09/01/2004 | EP1451330A1 Methods of preparing a targeting vector and uses thereof |
| 09/01/2004 | EP1451329A2 Genetic vaccine against human immunodeficiency virus |
| 09/01/2004 | EP1451328A2 Phytases and method for producing these phytases |
| 09/01/2004 | EP1451327A2 Compositions from the grasses lolium perenne and festuca arundinacea |
| 09/01/2004 | EP1451326A2 Protein kinase stress-related polypeptides and methods of use in plants |
| 09/01/2004 | EP1451325A2 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
| 09/01/2004 | EP1451323A2 Pharmaceutical compositions of marine sponge microciona prolifera |
| 09/01/2004 | EP1451322A2 Il-21 antagonists |
| 09/01/2004 | EP1451321A1 A method of genetic screening using an amplifiable gene |
| 09/01/2004 | EP1451318A1 Compilations of nucleic acids and arrays and methods of using them |
| 09/01/2004 | EP1451317A1 Methods of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof |
| 09/01/2004 | EP1451316A2 Method for producing transgenic birds and fish |
| 09/01/2004 | EP1451315A2 Human coagulation factor vii polypeptides |